Home / Program / 4/28 (Sun) / Boehringer Ingelheim
Boehringer Ingelheim

2024 APRC: Boehringer-Ingelheim Satellite Symposium

The management of obstructive airways diseases has evolved significantly with the identification of treatable traits, offering a personalized approach to patient care. This abstract explores the journey from theoretical concepts to practical implementation in clinical practice. By delineating the clinical course and evidence-based strategies for antifibrotic treatment in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), it delves into the complexities of disease progression and the rationale behind tailored therapeutic interventions. Through a synthesis of current research findings and clinical guidelines, this abstract elucidates the paradigm shift towards precision medicine in respiratory care, emphasizing the importance of early identification and targeted management of treatable traits to optimize patient outcomes.
Date: Sunday, Apr 28, 2024 | Time: 12:20-13:20 (GMT+8)
Topic Speaker Moderator
12:20-12:45 Treatable Traits in Obstructive Airways
Diseases: From Theory to Clinical Practice
Dr.Ying-Ming Tsai
Kaohsiung Medical University Chung-Ho Memorial Hospital
Dr. Diahn-Warng Perng
Taipei Veterans General Hospital
12:45-13:10 Clinical Course & Evidence-Based Approach
for Antifibrotic Treatment of IPF and PPF
Dr.Yueh-Feng Wen
National Taiwan University Hospital Hsin-Chu Branch
Dr. Horng-Chyuan Lin
Linkou Chang Gung Memorial Hospital
13:10-13:20 Panel discussion ALL